EcoDrugPlus

Serpin Peptidase Inhibitor, Clade C (Antithrombin), Member 1

Ensembl ID : ENSDARG00000042684
Gene Symbol: SERPINC1
8 Enzyme and pathways 5 Cross references
202 Possible Orthologues:

Si:ch211-264f5.8

Ensembl ID : ENSDARG00000078151
Gene Symbol: SI:CH211-264F5.8
6 Enzyme and pathways 3 Cross references
290 Possible Orthologues:

Si:ch211-270n8.1

Ensembl ID : ENSDARG00000045089
Gene Symbol: SI:CH211-270N8.1
6 Enzyme and pathways 4 Cross references
346 Possible Orthologues:

Si:ch211-79m20.1

Ensembl ID : ENSDARG00000086778
Gene Symbol: SI:CH211-79M20.1
18 Enzyme and pathways 5 Cross references
193 Possible Orthologues:

Si:ch73-383l1.1

Ensembl ID : ENSDARG00000090408
Gene Symbol: SI:CH73-383L1.1
5 Cross references
229 Possible Orthologues:

Si:ch73-90p23.1

Ensembl ID : ENSDARG00000097901
Gene Symbol: SI:CH73-90P23.1
7 Enzyme and pathways 5 Cross references
298 Possible Orthologues:

Si:dkey-145c18.3

Ensembl ID : ENSDARG00000078738
Gene Symbol: SI:DKEY-145C18.3
5 Cross references
155 Possible Orthologues:

Si:dkey-163m14.10

Ensembl ID : ENSDARG00000086262
Gene Symbol: SI:DKEY-163M14.10
2 Cross references
260 Possible Orthologues:

Si:dkey-163m14.2

Ensembl ID : ENSDARG00000059507
Gene Symbol: SI:DKEY-163M14.2
5 Cross references
260 Possible Orthologues:

Si:dkey-163m14.4

Ensembl ID : ENSDARG00000087469
Gene Symbol: SI:DKEY-163M14.4
3 Cross references
260 Possible Orthologues:

Si:dkey-163m14.6

Ensembl ID : ENSDARG00000090041
Gene Symbol: SI:DKEY-163M14.6
5 Cross references
260 Possible Orthologues:

Si:dkey-163m14.7

Ensembl ID : ENSDARG00000086236
Gene Symbol: SI:DKEY-163M14.7
5 Cross references
260 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).